Ibrunat Ibrutinib 140mg is an oral targeted therapy used to treat certain blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
| Manufacturer | Natco |
| Generic Name | Ibrutinib |
| Strength | 140mg |
| Pack size | 30 Capsules |
| Used For | Chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) |
Ibrukast Ibrutinib 140mg is an oral targeted therapy used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
| Generic Name | Ibrutinib |
| Strength | 140mg |
| Pack size | 30 Capsules |
| Used For | Chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) |
